To elucidate whether Fra-1 mediates chemotherapy resistance in GC cells by suppressing ferroptosis, we modulated Fra-1 expression levels and administered erastin, a ferroptosis inducer, in conjunction with CDDP treatment. This evidence concerns the gene FOSL1 and gastric cancer.